This story was reported and written by Staff Writers Mike Ward in the U.K. and Ilan Zipkin in the U.S.

In what could be a landmark decision with worldwide repercussions, the U.K.'s National Institute for Clinical Excellence (NICE) recommended late Friday that doctors in the National Health Service should not prescribe Relenza (zanamivir) to treat influenza during the coming flu season.